Net Medical Xpress Solutions Notes Congressional Proposal To Broaden Telemedicine Reimbursement
ALBUQUERQUE, N.M., Jan. 8, 2013 /PRNewswire/ -- Net Medical Xpress Solutions, Inc. (OTC Bulletin Board NMXC), said today that a Congressional proposal to increase telemedicine reimbursement could have a positive impact on the company's operations even as it contributes to lowering the country's healthcare costs.
The Telehealth Promotion Act of 2012 (H.R. 6719) sponsored by Congressman Mike Thompson would establish a federal reimbursement policy to ensure that no medical benefits are excluded as a result of being furnished by a telecommunications system. If passed, the bill is expected to increase access to telemedicine within Medicare, Medicaid, the Children's Health Insurance Program, TRICARE, federal employee health plans and the Department of Veterans Affairs.
CEO and President, Dick Govatski, said, "This proposed legislation underscores the growing acceptability of telemedicine as a key component of our health care system. The use of our telemedicine programs is already helping to lower health care costs here in New Mexico and this can easily be expanded nationwide. Among other advantages are incentivizing hospitals to lower readmissions by offering them a share of the total cost savings. Other benefits are allowing the medical community to use telemedicine as an equivalent substitute for in-person care and the use of remote monitoring to also help lower costs. We agree with those who say that passage of this legislation will almost instantly make our Federally-funded health care system more effective and more efficient."
About Net Medical Xpress Solutions, Inc:Net Medical Xpress' Telemedicine programs provide diagnostic and clinical medical services to mobile companies, urgent cares, hospitals, trauma centers, imaging centers, jails, nursing homes, corporate health departments, and out patient medical facilities. The company's proprietary, web-based XR-Express 510K FDA cleared PACS is Net Medical Xpress foundation software, which enables medical providers to make real-time assessments of patients' conditions and treatment needs.For more information, visit www.netmedical.com or www.nmxs.com or contact Dick Govatski, president and CEO, at 505-255-1999 or firstname.lastname@example.org. An investment profile for Net Medical Xpress is at http://www.hawkassociates.com/profile/nmxc.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert. For more investor-related questions contact Frank Hawkins, Hawk Associates, at 305-451-1888 or Dick Govatski at 505-255-1999 ( email@example.com). This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company's Forms 10-K and 10-Q filed with the SEC.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts